| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Envoy Medical, Inc.: Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th | 311 | Newsfile | Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health... ► Artikel lesen | |
| Di | Envoy Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Di | Envoy Medical, Inc.: Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th | 200 | Newsfile | Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company")... ► Artikel lesen | |
| 22.10. | Envoy Medical announces 1-for-10 reverse stock split | 6 | Investing.com | ||
| 22.10. | Envoy Medical, Inc.: Envoy Medical Announces Reverse Stock Split | 286 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully... ► Artikel lesen | |
| 20.10. | Envoy Medical, Inc.: Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design | 334 | Newsfile | Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final... ► Artikel lesen | |
| 16.10. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ENVOY MEDICAL Aktie jetzt für 0€ handeln | |||||
| 13.10. | Envoy Medical stock price target maintained at $2 by H.C. Wainwright | 1 | Investing.com | ||
| 12.10. | Envoy Medical reicht zweites FDA-Modul für Acclaim-Implantat ein | - | Investing.com Deutsch | ||
| 12.10. | Envoy Medical submits second FDA module for Acclaim implant | 2 | Investing.com | ||
| 12.10. | Envoy Medical, Inc.: Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant | 529 | Newsfile | Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October... ► Artikel lesen | |
| 07.10. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.10. | Lake Street stuft Envoy Medical mit "Buy" ein und sieht über 270 % Kurspotenzial | 1 | Investing.com Deutsch | ||
| 06.10. | Lake Street initiates Envoy Medical stock at buy on cochlear device | 2 | Investing.com | ||
| 22.09. | Envoy Medical receives patents in Canada and Hong Kong | 1 | Investing.com | ||
| 22.09. | Envoy Medical, Inc.: Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio | 462 | Newsfile | Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September... ► Artikel lesen | |
| 27.08. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | Envoy Medical: H.C. Wainwright senkt Kursziel wegen gestiegener Aktienanzahl | 1 | Investing.com Deutsch | ||
| 21.08. | H.C. Wainwright cuts Envoy Medical stock price target on share count | 1 | Investing.com | ||
| 10.08. | Envoy Medical, Inc. - 8-K, Current Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,300 | +1,72 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,840 | +1,09 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,56 | +3,50 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GERRESHEIMER | 31,820 | -1,49 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
23.10.2026 / 11:39 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| CONCENTRA GROUP | 41,190 | +1,48 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,325 | +1,96 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| BILLIONTOONE | 113,79 | -0,18 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| ESSILORLUXOTTICA | 178,65 | -1,00 % | 263 Prozent mehr KI-Brillen: Wie Meta und EssilorLuxottica den Optikmarkt verändern | ||
| HEARTFLOW | 59,69 | +1,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| NUWELLIS, INC | 6,440 | +19,04 % | Nuwellis: Interview With President And CEO Mike McCormick About Precision Fluid Management And Cardiorenal Care | ||
| CARL ZEISS MEDITEC | 35,000 | +0,81 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| INTUITIVE SURGICAL | 400,95 | +0,61 % | ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes? | ||
| KESTRA MEDICAL TECHNOLOGIES | 30,200 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| UNITEDHEALTH | 365,80 | -0,49 % | UnitedHealth Group To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Tuesday |